We are monitoring the impact of COVID-19 on Humira Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 9026
Share on
Share on

Global Humira Market Analysis - By Type (Humira Syringe, Humira Pen ), By Application (Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s Disease And Others), By Region ((North America (U.S., Canada), Europe (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of EU), Asia Pacific (India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC), Latin America (Brazil, Mexico, Argentina, Chile), Middle East and Africa (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA)) - Industry Size, Share, Trends, Growth, Forecast | 2019 - 2024

Pulished: February, 2020
ID: 9026
Pages: 120

Global Humira Market Size & Growth (2019 - 2024)

Globally, the size of the Humira Market is expected to grow at a healthy CAGR from 2019 to 2024. Humira was initially approved in the United States and is now available in more than 60 countries. Over the years, technological advances and increased R & D activity for the development of Humira biosimilars have created some growth opportunities for these drugs.

Humira is used for various diseases, where the patient fails to respond to any other treatments. Humira is also known as adalimumab, and this is used in the form of injections under the skin. Physicians generally prescribe this medication only when a patient has no response with the other treatment procedures. Initially, it was approved by the US government for the use of this medication for various diseases like rheumatoid arthritis, psoriatic arthritis, and others. The market size is expected to grow tremendously during the forecast period.

An increasing number of patients with diseases due to changes in lifestyles is a key driving factor for the market to grow. Rise in the capital income in both developed and developing countries is lavishing the demand of the market.

The forefront of driving the global Humira market is the increase in global arthritis. This, in turn, is mainly due to the rapid growth of the elderly population. Most women have arthritis in old age due to the loss of calcium in the body. Sedentary lifestyles have also led to the development of another condition called arthritis or psoriasis. They all contribute to the consumption of the product, along with other factors such as an increased prevalence of Crohn's disease and ulcerative colitis. Also, factors such as improved disease diagnostics and strong support for effective biopharmaceuticals will drive the growth of the global Humira market. However, due to its biological properties, Humira is an expensive drug. Monthly costs range from $ 2,000 to $ 3,000. This is one of the factors that hinder the market growth.

The emergence of the latest technologies and the launch of various treatment procedures in favor of the end-users is likely to bolster the growth of the market. Increasing support from the government through investments is to surge growth opportunities for the market.

Multinational companies are actively investing to take advantage of untapped opportunities in Latin America and the Asia-Pacific region, and opportunities for market growth will remain soon. After the blockbuster drug patent expired, the entry of Humira provides new opportunities for key players in the market.

However, the lack of skilled persons in treating the disease with proper dosage form is slightly declining the growth of the Humira market. High cost for treatment procedures remained a challenging factor for the market.

The high cost of clinical trials and R & D is a significant challenge witnessed by market operators. Despite high R & D spending, manufacturers need to keep their products low, further limiting growth opportunities in the global Humira market. Lack of reimbursement for biopharmaceutical treatments also harms the market.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Type, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Analysed

Pfizer, Amgen, Novartis AG, Boehringer Ingelheim GmbH, Mylan N.V., and AbbVie among others.

 

This research report on the Global Humira Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Humira Market - By Type

  • Humira Syringe
  • Humira Pen

On the basis of type, the Humira syringes segment is having the highest shares of the market. Rising the elderly population globally is greatly influencing the growth of the market.

Humira Market - By Application

  • Ankylosing Spondylitis
  • Rheumatoid Arthritis
  • Crohn’s Disease
  • Others

On the basis of application, the Ankylosing spondylitis application segment is dominating with the largest shares of the market.

Humira Market - By Region

  • North America (U.S., Canada)
  • Europe (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of EU)
  • Asia Pacific (India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC
  • Latin America (Brazil, Mexico, Argentina, Chile)
  • Middle East and Africa (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA)

North America has the largest market share with the latest technology developments and the introduction of a variety of innovative drugs to enhance treatment procedures.

Asia pacific is following North America is dominating the shares of the market with the rise in the incidences of Crohn's diseases.

Europe is growing steadily form the past few years with the rising scale of pharmaceutical companies and growing demand to expand productivity. The Middle East and Africa are inclined to huge growth opportunities in the coming years.  

Brazil, Mexico, and Argentina are the most profitable countries in Latin America for sales of Humira. Of these countries, Brazil has a regulatory policy for biopharmaceuticals and is, therefore, a major market. In addition, Brazilian patients are increasingly aware of biopharmaceutical preferences, leading the Humira market in the area. 

Most promising companies leading in the Global Humira Market profiled in this report are:

  • Pfizer
  • Amgen
  • Novartis AG
  • Boehringer Ingelheim GmbH
  • Mylan N.V.
  • AbbVie
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Type
      1. humira syringe
      2. humira pen
      3. Y-o-Y Growth Analysis, By Type
      4. Market Attractiveness Analysis, By Type
      5. Market Share Analysis, By Type
    2. By Application
      1. ankylosing spondylitis
      2. rheumatoid arthritis
      3. crohn’s disease
      4. others
      5. Y-o-Y Growth Analysis, By Application
      6. Market Attractiveness Analysis, By Application
      7. Market Share Analysis, By Application
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Type
        3. By Application
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Type
        3. By Application
      5. Market Share Analysis      
        1. By Geographical Area
        2. By Type
        3. By Application
    2. North America
      1. Introduction
      2. US
      3. Canada
    3. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
    4. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
    6. Middle East & Africa
      1. Introduction
      2. Middle East
      3. Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Pfizer Inc.
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Amgen
    3. Novartis AG
    4. Boehringer Ingelheim GmbH
    5. Mylan N.V.
    6. AbbVie
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of raw materials, by application, along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Humira Market

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample